LA
TCON
Linden Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-454,916
| Closed | -$132K | – | 382 |
|
|
2023
Q2 | $132K | Hold |
454,916
| – | – | ﹤0.01% | 245 |
|
|
2023
Q1 | $860K | Hold |
454,916
| – | – | 0.01% | 249 |
|
|
2022
Q4 | $678K | Hold |
454,916
| – | – | 0.01% | 323 |
|
|
2022
Q3 | $760K | Hold |
454,916
| – | – | 0.01% | 386 |
|
|
2022
Q2 | $910K | Hold |
454,916
| – | – | 0.01% | 412 |
|
|
2022
Q1 | $1.2M | Buy |
454,916
+170,668
| +60% | +$449K | 0.01% | 474 |
|
|
2021
Q4 | $787K | Hold |
284,248
| – | – | ﹤0.01% | 506 |
|
|
2021
Q3 | $1.1M | Hold |
284,248
| – | – | 0.01% | 415 |
|
|
2021
Q2 | $1.85M | Hold |
284,248
| – | – | 0.01% | 446 |
|
|
2021
Q1 | $2.34M | Hold |
284,248
| – | – | 0.02% | 427 |
|
|
2020
Q4 | $3.33M | Hold |
284,248
| – | – | 0.02% | 274 |
|
|
2020
Q3 | $1.47M | Hold |
284,248
| – | – | 0.02% | 221 |
|
|
2020
Q2 | $557K | Hold |
284,248
| – | – | 0.01% | 204 |
|
|
2020
Q1 | $475K | Hold |
284,248
| – | – | 0.01% | 177 |
|
|
2019
Q4 | $665K | Sell |
284,248
-2,558,229
| -90% | -$5.98M | 0.01% | 180 |
|
|
2019
Q3 | $1.27M | Hold |
2,842,477
| – | – | 0.02% | 149 |
|
|
2019
Q2 | $1.93M | Hold |
2,842,477
| – | – | 0.03% | 137 |
|
|
2019
Q1 | $3.89M | Hold |
2,842,477
| – | – | 0.09% | 99 |
|
|
2018
Q4 | $1.79M | Hold |
2,842,477
| – | – | 0.05% | 104 |
|
|
2018
Q3 | $5.83M | Hold |
2,842,477
| – | – | 0.18% | 76 |
|
|
2018
Q2 | $7.68M | Hold |
2,842,477
| – | – | 0.24% | 70 |
|
|
2018
Q1 | $5.88M | Buy |
+2,842,477
| New | +$5.88M | 0.14% | 97 |
|